{"id":"W2304028829","doi":"10.1016/j.jaad.2016.02.1164","title":"Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":83,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Innovaderm (Canada)","funders":"Celgene","keywords":"Apremilast; Medicine; Psoriasis; Dermatology; Phase (matter); Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003449574,0.0004306063,0.003656287,0.0005944331,0.0001034841,0.000008019258,0.0005456987,0.0003076606,0.000007351574],"category_scores_gemma":[0.00183094,0.0001961588,0.0004650084,0.0009113605,0.0007851908,0.0001588305,0.0001119127,0.0003623579,2.794662e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000078123,"about_ca_system_score_gemma":0.0001737264,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003773189,"about_ca_topic_score_gemma":0.0001725144,"domain_scores_codex":[0.9861067,0.008964414,0.00381011,0.0004660627,0.0002597743,0.0003929676],"domain_scores_gemma":[0.9844422,0.01018917,0.004747035,0.0004310955,0.0001137616,0.00007677884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6736608,0.008796572,0.1191606,0.00003835043,0.005221413,0.00001677905,0.0080208,0.0000894572,0.01809539,0.00000740359,0.00007772181,0.1668148],"study_design_scores_gemma":[0.6172274,0.0341321,0.2794473,0.0008171689,0.008936411,0.00008664815,0.00139811,0.00005765082,0.0573295,0.00008866127,0.00009624926,0.0003827942],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954491,0.001248176,0.00001692282,0.000930048,0.0002796461,0.001560861,0.0005084755,0.000003799506,0.000003012496],"genre_scores_gemma":[0.9980282,0.001474573,0.0002453251,0.0001017708,0.00006387179,0.00004117725,0.00002203937,0.00001837491,0.000004668871],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.166432,"threshold_uncertainty_score":0.7999123,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.042796572009189,"score_gpt":0.3684748574190304,"score_spread":0.3256782854098414,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}